Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Cymabay Therapeutics Inc. (CBAY)

« Back to company index

CBAY Chatter Timeline

Stock Ticker for CBAY

Most Active Tweeters for CBAY

UserTweets
@Gambiste1 13
@AmericanBanking 11
@1MinuteStock 11
@pennyflipper 6
@TickerReport 6

Recent Tweets for CBAY

AmericanBanking @AmericanBanking
B. Riley Analysts Give CymaBay Therapeutics $CBAY a $7.00 Price Target https://t.co/uOOJaySru4 #stocks
June 17th 2019, 4:06pm
LifeSciAdvisors @LifeSciAdvisors
CymaBay Therapeutics $CBAY to Participate in the Raymond James Life Sciences and MedTech Conference https://t.co/wIsIAJECSW
June 17th 2019, 3:06pm
dailypoliticaln @dailypoliticaln
Analysts Anticipate CymaBay Therapeutics Inc $CBAY Will Announce Earnings of -$0.36 Per Share https://t.co/M5kNxzJLib
June 17th 2019, 1:06pm
AmericanBanking @AmericanBanking
Critical Review: CymaBay Therapeutics $CBAY and Constellation Pharmaceuticals $CNST https://t.co/SvlxSNokjo #stocks
June 17th 2019, 10:06am
dailypoliticaln @dailypoliticaln
Head-To-Head Survey: CymaBay Therapeutics $CBAY versus Constellation Pharmaceuticals $CNST https://t.co/rIhVQnXlcK
June 17th 2019, 10:06am
HeadlinesFin @HeadlinesFin
What's in CymaBay Therapeutics, Inc. $CBAY After Forming Multiple Top? https://t.co/nmqXa8bLfL
June 17th 2019, 10:06am
ThisLincolnian @ThisLincolnian
CymaBay Therapeutics $CBAY Price Target Lowered to $12.00 at Citigroup https://t.co/dfpIPmZLQ6
June 17th 2019, 4:06am
PriceTargetsNet @PriceTargetsNet
$CBAY TARGET PRICE LOWERED AT B RILEY FBR INC. https://t.co/ThOIqaTDrV
June 17th 2019, 2:06am
DataTrials @DataTrials
$CBAY Phase 2 Seladelpar (MBX-8025) in Subjects With Primary Biliary Cholangitis (PBC)… Estimate Primary Completion Date - 07/2019
June 16th 2019, 1:06pm
TickerReport @TickerReport
Citigroup Trims CymaBay Therapeutics $CBAY Target Price to $12.00 https://t.co/phPMmFPfkN
June 16th 2019, 5:06am
dispatchtribune @dispatchtribune
CymaBay Therapeutics $CBAY Rating Lowered to Sell at BidaskClub https://t.co/hm9gPZY6oo
June 16th 2019, 2:06am
bbnsnews @bbnsnews
Piper Jaffray Companies Lowers CymaBay Therapeutics $CBAY Price Target to $8.00 https://t.co/s6WCq8Xc9y
June 15th 2019, 8:06am
stocknewstimes @stocknewstimes
CymaBay Therapeutics $CBAY Shares Gap Up to $6.17 https://t.co/BaO6fpqOlG
June 15th 2019, 8:06am
SleekMoneycom @SleekMoneycom
CymaBay Therapeutics $CBAY Shares Gap Up to $6.17 https://t.co/bfPUaBhFLN #investing
June 15th 2019, 8:06am
storminvestor @storminvestor
CymaBay Therapeutics $CBAY Shares Gap Up to $6.17 https://t.co/iJee9aLxdf #markets
June 15th 2019, 8:06am
OlympiaReport @OlympiaReport
HC Wainwright Reiterates “Buy” Rating for CymaBay Therapeutics $CBAY https://t.co/908w3OJazF
June 15th 2019, 7:06am
registrarjourn @registrarjourn
B. Riley Reiterates “$11.00” Price Target for CymaBay Therapeutics $CBAY https://t.co/ft54Ksxz3s
June 15th 2019, 3:06am
EnterpriseLeade @EnterpriseLeade
B. Riley Reiterates “$11.00” Price Target for CymaBay Therapeutics $CBAY https://t.co/eBac6iFoAH
June 15th 2019, 3:06am
dakotafinancial @dakotafinancial
Oppenheimer Reiterates “$12.00” Price Target for CymaBay Therapeutics $CBAY https://t.co/O6V6gHZ4Vi
June 15th 2019, 3:06am
dispatchtribune @dispatchtribune
Research Analysts Issue Forecasts for CymaBay Therapeutics Inc’s FY2021 Earnings $CBAY https://t.co/Z48oillzqJ
June 15th 2019, 2:06am
BlueBioNow @BlueBioNow
$CBAY a bit volatility -5.93 % https://t.co/5FMbJjXg5G
June 15th 2019, 1:06am
fintel_io @fintel_io
$CBAY / Cymabay Therapeutics files form 8-K https://t.co/mcmGG9NKvQ - Departure of Directors or Certain Officers; E… https://t.co/aO0MO6FnXG
June 14th 2019, 4:06pm
Stock_News_Now @Stock_News_Now
$CBAY: New SEC Filing for CBAY: Form 8-K (No. 0001193125-19-173660): https://t.co/J507QKoxjD
June 14th 2019, 4:06pm
MarketRealist @MarketRealist
CymaBay or Viking Therapeutics: Which Is the Better Pick? $CBAY $VKTX https://t.co/kwYHlj042D
June 14th 2019, 1:06pm
RyanSTTrader @RyanSTTrader
$CBAY Buy the dip? More like sell
June 14th 2019, 12:06pm
IntensityStocks @IntensityStocks
12:35:11 PM Another LOD $CBAY $6.33 -6.2% ON 710K VOL [ISW Bearish Watch/Scan]
June 14th 2019, 12:06pm
IntensityStocks @IntensityStocks
11:46:28 AM Makes fresh LOD $CBAY $6.33 -6.2% ON 620K VOL [ISW Bearish Watch/Scan]
June 14th 2019, 11:06am
TranscriptDaily @TranscriptDaily
CymaBay Therapeutics $CBAY Price Target Cut to $8.00 https://t.co/u1GNBnq2hp
June 14th 2019, 9:06am
dailypoliticaln @dailypoliticaln
Oppenheimer Reiterates “$12.00” Price Target for CymaBay Therapeutics $CBAY https://t.co/mNzCtcXGKk
June 14th 2019, 8:06am
TickerReport @TickerReport
CymaBay Therapeutics $CBAY Receives Buy Rating from HC Wainwright https://t.co/axxErAeZ3l
June 14th 2019, 8:06am
AmericanBanking @AmericanBanking
FY2021 Earnings Forecast for CymaBay Therapeutics Inc $CBAY Issued By Oppenheimer https://t.co/aq5GEyFZgr #stocks
June 14th 2019, 8:06am
TickerReport @TickerReport
Oppenheimer Brokers Reduce Earnings Estimates for CymaBay Therapeutics Inc $CBAY https://t.co/3H4OQGpmv8
June 14th 2019, 8:06am
TickerReport @TickerReport
BidaskClub Downgrades CymaBay Therapeutics $CBAY to Sell https://t.co/1RL93Bgptu
June 14th 2019, 2:06am
1MinuteStock @1MinuteStock
We calculated 21-day Expected Return of $CBAY for you: -41.66% https://t.co/dkVwertBjC
June 13th 2019, 4:06pm
TickerReport @TickerReport
CymaBay Therapeutics $CBAY Shares Gap Up to $6.17 https://t.co/1aioVYNXBc
June 13th 2019, 3:06pm
WingTrades @WingTrades
Nice pickup on $CBAY; this had a great morning and is consolidating now
June 13th 2019, 1:06pm
LargeVoidBot @LargeVoidBot
Daily Reversal (13:01): $CBAY Last: 6.67; pHigh: 6.62; rVol: 1.122; pClose: 6.17; LOD: 6.0400; Perf: 8.1%
June 13th 2019, 1:06pm
ProTradersNews @ProTradersNews
$CBAY $BLX: Hedge Funds Have Never Been This Bullish On CymaBay …: https://t.co/WdUItYE5ZH
June 13th 2019, 12:06pm
BiotechMoney18 @BiotechMoney18
RT @TradersFish: $SVRA -76.63% premarket, fail data $CBAY -45.45 % from fail data for risk mitigate use our #BiotechCalculator to help red…
June 13th 2019, 9:06am
TradersFish @TradersFish
$SVRA -76.63% premarket, fail data $CBAY -45.45 % from fail data for risk mitigate use our #BiotechCalculator to h… https://t.co/lOHiHrHRFd
June 13th 2019, 9:06am
OlympiaReport @OlympiaReport
CymaBay Therapeutics $CBAY Downgraded to “Sell” at BidaskClub https://t.co/t1H6uvbb3Z
June 13th 2019, 8:06am
dispatchtribune @dispatchtribune
CymaBay Therapeutics $CBAY Receives “Buy” Rating from HC Wainwright https://t.co/bF3Kj6k59H
June 13th 2019, 8:06am
AmericanBanking @AmericanBanking
Citigroup Trims CymaBay Therapeutics $CBAY Target Price to $12.00 https://t.co/1B6tE87Fz9 #stocks
June 13th 2019, 8:06am
AmericanBanking @AmericanBanking
Citigroup Trims CymaBay Therapeutics $CBAY Target Price to $12.00 https://t.co/NYpt3fT9AM #stocks
June 13th 2019, 8:06am
ZolmaxNews @ZolmaxNews
CymaBay Therapeutics $CBAY PT Lowered to $12.00 https://t.co/qcHHBiCE6z
June 13th 2019, 7:06am
stocknewstimes @stocknewstimes
Brokerages Expect CymaBay Therapeutics Inc $CBAY Will Announce Earnings of -$0.36 Per Share https://t.co/ISLn6PRFEd
June 13th 2019, 7:06am
SleekMoneycom @SleekMoneycom
Brokerages Expect CymaBay Therapeutics Inc $CBAY Will Announce Earnings of -$0.36 Per Share https://t.co/P6ZBoZ12oM #investing
June 13th 2019, 7:06am
AmericanBanking @AmericanBanking
CymaBay Therapeutics Inc Forecasted to Post FY2021 Earnings of -$1.60 Per Share $CBAY https://t.co/9c8nFvGWUq #stocks
June 13th 2019, 6:06am
dakotafinancial @dakotafinancial
Piper Jaffray Companies Comments on CymaBay Therapeutics Inc’s FY2021 Earnings $CBAY https://t.co/c9sfQ9mVL4
June 13th 2019, 6:06am
ThisLincolnian @ThisLincolnian
Piper Jaffray Companies Trims CymaBay Therapeutics $CBAY Target Price to $8.00 https://t.co/uHTmpYmMs9
June 13th 2019, 6:06am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.